NCT04040205 2025-07-20Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway AlterationMedical College of WisconsinPhase 2 Recruiting44 enrolled
NCT02846987 2025-06-05Study of Abemaciclib in Dedifferentiated LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting33 enrolled